CMOTEC_B: Animal Care sales hit records and TSE tech achieved scientific validation, fueling growth

About this update from Scandinavian Chemotech Ab Class B

Record-breaking Animal Care sales and a landmark TSE veterinary trial drove strong H1 2025 growth, though continued losses and the need for additional funding remain. US market adoption surged, and a SEK 4.85M share issue strengthened capital.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Scandinavian Chemotech Ab Class B